You signed the contract. Now close the readiness gap.
You have signed — or are weighing — an AI, patient-access, or revenue-cycle solution. The contract is in place. The readiness gap is not. Threshold FDE closes that gap, names the owners on both sides, and stays through go-live and stabilization until adoption is measured against cell six of the Rules of Engagement.
What turns a signed contract into a deployment without measured adoption.
These are not vendor problems — they are operating problems, surfaced during health-system deployments where the named client-side owner was either late or absent. Each one is the same shape: a tool goes live on a procurement timeline, not on a workflow timeline.
Signed contract, no measurable adoption.
Tools go live on procurement timelines — not on workflow readiness. The question is not “did it deploy” but “are the named owners moving the cell-six number on the operating rhythm the integration partners are using.” Adoption is measured, not declared.
Vendor stack fragmented.
A point solution lands clean in isolation — and breaks the operating cadence against the EHR, scheduling, and prior-auth workflows it sits next to. Cross-vendor coordination is where readiness stalls, quietly, off the deployment page.
Go-live as finish line.
Live is the moment work begins — not the moment work ends. The threshold we measure against is adoption: frontline usage, throughput, error rate, financial clearance, owned by a named leader who stays after we leave.
Move from ‘Live’ to ‘Adopted’—we own the stabilization of your clinical and technical workflows.
Leadership changes. Vendors change. The critical workflow doesn’t get to stall — we hold it steady.
The intake is four fields, two minutes. The form is pre-tagged “For health systems” so the engagement team reads it with the right context. We respond within two business days with a named FDE lead and the date for the first engagement call.
Four fields, two minutes. The intake is monitored by the FDE engagement team — not a routing bot.